IP Library Granted Patent US 8,252,309
Granted Patent B2
US 8,252,309 · App. 11/253,806 · Granted Aug 28, 2012

Dietary supplement energy-providing to skeletal muscles

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,252,309
App. No.
11/253,806
Granted
Aug 28, 2012
Kind
B2
Abstract

Dietary supplements—providing energy and strengthening skeletal muscles and facilitating skeletal muscles ability to sustain prolonged periods of physical activity—containing propionyl-L-carnitine or one of its salts, coenzyme Q 10 , nicotinamide, riboflavin, pantothenic acid and optionally other components such as amino acids and creatines.

Claims (36)

1. A method of facilitating skeletal muscles ability to sustain prolonged periods of intense physical activity and providing energy and strengthening to skeletal muscles comprising

administering to individuals engaging in intense and prolonged sporting activities in need thereof a dietary supplement consisting of:

(a) propionyl L-carnitine or a pharmacologically acceptable salt thereof;

(b) coenzyme Q 10 ;

(c) riboflavin; and

(d) pantothenic acid; and

facilitating said skeletal muscles ability to sustain said prolonged periods of intense physical activity and providing said energy and strengthening to said skeletal muscles in said individuals.

2. The method of claim 1 wherein the pharmacologically acceptable salt is selected from the group consisting of chloride, bromide, iodide, aspartate, acid aspartate, citrate, acid citrate, phosphate, acid phosphate, fumarate, acid fumarate, glycerophosphate, glucose phosphate, lactate, maleate, acid maleate, mucate, orotate, oxalate, acid oxalate, sulphate, acid sulphate, tartrate, trichloroacetate, trifluoroacetate and methane sulphonate.

3. A method of facilitating skeletal muscles ability to sustain prolonged periods of intense physical activity and providing energy and strengthening to skeletal muscles comprising

administering to individuals engaging in intense and prolonged sporting activities in need thereof a dietary supplement consisting of:

(a) propionyl L-carnitine or a pharmacologically acceptable salt thereof;

(b) coenzyme Q 10 ;

(c) riboflavin; and

(d) pantothenic acid;

and at least one of the following components:

(f) an amino acid selected from the group consisting of valine, leucine and isoleucine or mixtures thereof;

(g) a creatine selected from the group consisting of creatine and phosphocreatine or mixtures thereof, and

facilitating said skeletal muscles ability to sustain said prolonged periods of intense physical activity and providing said energy and strengthening to said skeletal muscles in said individuals.

4. The method of claim 1 wherein the weight ratio (a):(b):(c):(d) ranges from 10:0.04:0.08:0.4 to 1:4:4:20.

5. The method of claim 4 wherein the weight ratio (a):(b):(c):(d) ranges from 10:2:2:2 to 1:1:1:5.

6. The method of claim 1 wherein the composition is in a unit dosage form consisting of:

propionyl L-carnitine from 50 mg to 2.000 mg

coenzyme Q 10 from 5 mg to 200 mg

riboflavin from 5 mg to 200 mg

pantothenic acid from 10 mg to 1.000 mg.

7. The method of claim 1 wherein the composition is in a unit dosage form consisting of:

(a) propionyl L-carnitine from 250 mg;

(b) coenzyme Q 10 20 mg;

(c) riboflavin 20 mg; and

(d) pantothenic acid 20 mg.

8. The method of claim 3 wherein the composition is in a unit dosage form consisting of:

(a) propionyl L-carnitine or a pharmacologically acceptable salt thereof;

(b) coenzyme Q 10 ;

(c) riboflavin;

(d) pantothenic acid; and

(e) creatine.

Assignments (4)
CHANGE OF ADDRESS Recorded Oct 15, 2019
From: ALFASIGMA S.P.A.
To: ALFASIGMA S.P.A.
Reel/Frame 050727/0652 →
MERGER Recorded Nov 14, 2017
From: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
To: ALFASIGMA S.P.A.
Reel/Frame 044760/0906 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2009
From: SIGMA-TAU HEALTHSCIENCE S.P.A.
To: SIGMA TAU - INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
Reel/Frame 022296/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 23, 2005
From: GAETANI, FRANCO
To: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
Reel/Frame 017273/0423 →